Dermatology

The winner is Tony Priestley, a research scientist at Endo Pharmaceuticals.

Biogen, Portola ink agreement for autoimmune therapeutics

Medicis, a specialty pharmaceutical company focused on the treatment of dermatological and aesthetic conditions, has announced that it emerged as the successfully bidder at Graceway Pharmaceuticals, LLC’s bankruptcy auction for substantially all of Graceway’s outstanding U.S and Canadian pharmaceutical assets.

Merck Serono and Ono Pharmaceutical to develop oral multiple sclerosis drug and cancer immunotherapy

The research team found that a point mutation in the AKT1 gene activates the sporadic tissue growth characteristic of Proteus Syndrome, and their findings have implications for both drug therapies -- and even cancer.

Canadian pharma snags dermatology assets with two acquisitions totaling $770 million

Continuing its growth-through- acquisition strategy, Valeant gets ready to expand its already burgeoning dermatology presence by buying Dermik Laboratories Inc. from Sanofi

Strategic agreement to focus on improving awareness, treatments of disease

Creation of new strategic platform based on tissue regeneration using cell-based therapies complements Shire\'s existing specialist physician focus and biologics manufacturing capability

IVAX Diagnostics Inc. reported net revenues of $4.1 million in the first quarter of 2011, down from $4.65 million last year.

Drug from Roche and Daiichi Sankyo shows death reduction of 63 percent among advanced melanoma patients